Connect your AI

Carlsmed, Inc. Common Stock CARL Q2 2025 earnings

Reported August 28, 2025 · After market close

Revenue$12.1MBeat by $95.8K Diluted EPS-$1.47Beat by $0.05

Revenue estimate$12.0M

EPS estimate-$1.52

Next report

Jul 21, 2026 (In 3 weeks)

Revenue estimate$18.0M

EPS estimate-$0.43

Financials

Q2 2025

Income statement

Revenue$12.1M+98.7%

Gross profit$8.9M+94.4%

Operating income-$6.5M-2.9%

Net income-$6.8M-7.8%

EPS (diluted)-$1.47+5.2%

Balance sheet

Cash & equivalents$33.5M-12.3%

Total debt$17.7M—

Total equity-$83.1M-43.9%

Total assets$53.3M—

Cash flow

Operating cash flow-$7.0M—

CapEx$327.0K—

Free cash flow-$7.4M—

Valuation & ratios

Profitability

Gross margin74%—

Operating margin-64.5%—

Net margin-65.4%—

FCF margin-71.9%—

Returns & leverage

Current ratio4.9×—

Versus estimates

Revenue

Q1 2026$16.1MBeat by $1.2M Q4 2025$15.2MBeat by $443.8K Q3 2025$13.1MMiss by $1.8M

Q2 2025$12.1MBeat by $95.8K

Diluted EPS

Q1 2026-$0.32Beat by $0.11 Q4 2025-$0.32Beat by $0.11 Q3 2025-$0.40Beat by $0.05

Q2 2025-$1.47Beat by $0.05

Ask the moment Carlsmed, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk

Questions, answered.

When did Carlsmed, Inc. Common Stock report Q2 2025 earnings?: Carlsmed, Inc. Common Stock (CARL) reported Q2 2025 earnings on August 28, 2025 after market close.
What were Carlsmed, Inc. Common Stock's Q2 2025 revenue and EPS?: Carlsmed, Inc. Common Stock reported revenue of $12.1M and diluted EPS of $-1.47 for Q2 2025.
Did Carlsmed, Inc. Common Stock beat estimates in Q2 2025?: Revenue beat the consensus estimate of $12.0M by $95.8K. EPS beat the consensus estimate of $-1.52 by $0.05.
Where can I find Carlsmed, Inc. Common Stock's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0000950170-25-111953) directly on SEC EDGAR. The filing index links above go to sec.gov.